Spanish Red Biotech Pipeline
< Back
Diagnostics and Personalized Medicine
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Diagnostics and Personalized Medicine
IRYCIS
Diagnosis of melanoma with support of AI
Type:
Diagnostic
Therapeutic area:
Dermatology
Indication:
Artificial intelligence in dermatology
Phase:
5
Ready to Market
,
4
Register
,
3
Clinical validation
,
2
Preclinical Validation
,
1
R+D
Studies location: